Login / Signup

Upregulation of ESPL1 is associated with poor prognostic outcomes in endometrial cancer.

Yuzhong YangYing ShengJinhua ZhengAiyu MaShaohua ChenJing LinXiaozhen YangYuanna LiangYan ZhangXiang Zheng
Published in: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals (2024)
has the potential to serve as a diagnostic and prognostic biomarker in EC, highlighting its significance in the management of EC patients.
Keyphrases
  • endometrial cancer
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • cell proliferation
  • poor prognosis
  • type diabetes
  • risk assessment
  • human health